Hepatitis B virus infection in Saudi Arabia and the UAE: Public health challenges and their remedial measures.
Barriers
Challenges
Hepatitis-B virus
Patient knowledge
Social stigma
Journal
Journal of infection and public health
ISSN: 1876-035X
Titre abrégé: J Infect Public Health
Pays: England
ID NLM: 101487384
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
09
03
2023
revised:
02
06
2023
accepted:
17
07
2023
medline:
11
8
2023
pubmed:
24
7
2023
entrez:
23
7
2023
Statut:
ppublish
Résumé
Hepatitis B virus (HBV) infection is a major public health concern globally with higher prevalence in Middle Eastern countries. Both Saudi Arabia and the UAE face critical challenges in HBV treatment and management despite the implementation of a mass vaccination program. This review aimed to understand the gaps and unmet needs related to HBV infection, public health challenges associated with its diagnosis, and treatment barriers in Saudi Arabia and the UAE. Additionally, the review aimed to provide the best practices in the HBV care pathway for effective remedial measures and disease reduction. The literature search was done from Pubmed. The lack of disease awareness and knowledge about disease transmission among patients and their family members and healthcare professionals, lack of proper screening, underdiagnosis, social stigma, lack of established referral system, and treatment cost are the primary barriers to HBV diagnosis and management. Appropriate healthcare initiatives should be undertaken to lower the disease burden in Saudi Arabia and the UAE.
Sections du résumé
BACKGROUND
BACKGROUND
Hepatitis B virus (HBV) infection is a major public health concern globally with higher prevalence in Middle Eastern countries. Both Saudi Arabia and the UAE face critical challenges in HBV treatment and management despite the implementation of a mass vaccination program. This review aimed to understand the gaps and unmet needs related to HBV infection, public health challenges associated with its diagnosis, and treatment barriers in Saudi Arabia and the UAE. Additionally, the review aimed to provide the best practices in the HBV care pathway for effective remedial measures and disease reduction.
METHODS
METHODS
The literature search was done from Pubmed.
RESULTS
RESULTS
The lack of disease awareness and knowledge about disease transmission among patients and their family members and healthcare professionals, lack of proper screening, underdiagnosis, social stigma, lack of established referral system, and treatment cost are the primary barriers to HBV diagnosis and management.
CONCLUSION
CONCLUSIONS
Appropriate healthcare initiatives should be undertaken to lower the disease burden in Saudi Arabia and the UAE.
Identifiants
pubmed: 37482014
pii: S1876-0341(23)00242-3
doi: 10.1016/j.jiph.2023.07.008
pii:
doi:
Substances chimiques
Hepatitis B Antibodies
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1410-1417Informations de copyright
Copyright © 2023. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest We have no conflict of interest to declare.